Drug-Resistant Tuberculosis among Children, China, 2006-2015

Emerg Infect Dis. 2017 Nov;23(11):1800-1805. doi: 10.3201/eid2311.170234.

Abstract

Microbial drug resistance has become a major public health concern worldwide. To acquire epidemiologic data on drug-resistant tuberculosis (DR TB) among children, a major cause of illness and death for this population, we conducted a retrospective study of 2006-2015 data from 36 TB prevention and control institutions in Shandong Province, China. A total of 14,223 new TB cases, among which children (<18 years of age) accounted for only 5.5%, were caused by culture-confirmed Mycobacterium tuberculosis. Among children with TB, 18.9% had DR TB and 6.9% had multidrug-resistant TB. Over the past decade, the percentage of DR TB; multidrug-resistant TB; and overall first-line drug resistance for isoniazid, rifampin, ethambutol, and streptomycin among children increased significantly (at least 12%). Understanding the long-term trends of DR TB among children can shed light on the performance of TB control programs, thereby contributing to global TB control.

Keywords: China; children; drug-resistant tuberculosis; epidemiology; pediatric tuberculosis; primary transmission; tuberculosis and other mycobacteria.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • China / epidemiology
  • Cohort Studies
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Retrospective Studies
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Tuberculosis, Multidrug-Resistant / physiopathology
  • Young Adult